Average Co-Inventor Count = 10.18
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (38 from 125 patents)
2. Valo Health, Inc. (5 from 29 patents)
3. Valo Early Discovery, Inc. (4 from 15 patents)
47 patents:
1. 12264137 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
2. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
3. 11279681 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
4. 11274084 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
5. 11274085 - 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
6. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors
7. 11084831 - Benzopiperazine compositions as BET bromodomain inhibitors
8. 10995078 - Compounds and compositions for inhibition of FASN
9. 10988450 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
10. 10829462 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
11. 10829461 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
12. 10822316 - 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
13. 10800750 - Compounds and compositions for inhibition of FASN
14. 10703764 - Benzopiperazine compositions as BET bromodomain inhibitors
15. 10611750 - Tetrahydroquinoline compositions as bet bromodomain inhibitors